Effect of the antihepcidin Spiegelmer lexaptepid on inflammation-induced decrease in serum iron in humans.

Lucas T van Eijk1, Aaron S E John1, Frank Schwoebel2

  • 1Department of Intensive Care Medicine, and Radboud Institute for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands;

Blood
|August 29, 2014
PubMed
Summary

Lexaptepid, an anti-hepcidin oligonucleotide, effectively prevented a drop in serum iron during experimental inflammation. This demonstrates its potential for treating anemia of inflammation.